T2 Biosystems To Attend Upcoming Investor Conferences

2024-08-01 04:17:39

(MENAFN- GlobeNewsWire - Nasdaq) LEXINGTON, Mass., Aug. 01, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced plans to participate in two upcoming investor conferences in August 2024:

Canaccord Genuity Annual Growth Conference in Boston, Massachusetts. Management is scheduled to host a fireside chat on Wednesday, August 14, 2024, at 10:30am ET.

Sidoti Micro-Cap Conference, virtual participation. Management is scheduled to present on Thursday, August 15, 2024, at 1:00pm ET.

Interested parties may access live and recorded webcasts of the presentations on the“Investors” section of the Company's website at

About T2 Biosystems
T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems' products include the T2Dx® Instrument, the T2Bacteria® Panel, the T2Candida® Panel, the T2Resistance® Panel, and the T2BiothreatTM Panel, and are powered by the proprietary T2 Magnetic Resonance (T2MR®) technology. T2 Biosystems has an active pipeline of future products, including the U.S. T2Resistance Panel, the Candida auris test, and the T2LymeTM Panel. For more information, please visit .

Investor Contact:
Philip Trip Taylor, Gilmartin Group
...
415-937-5406

MENAFN01082024004107003653ID1108508198

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.